Beilstein J. Org. Chem. 2013, 9, 705–709.
through a Celite® bed, and the filtering bed was washed with 68.5 (C-4C), 68.2 (C-4B), 67.5 (C-3B), 61.7 (C-6C), 35.9 (CH2),
CH2Cl2 (50 mL). The combined filtrate was concentrated under 20.9, 20.8, 20.7 (3 C), 20.6 (3 C) (8 COCH3), 17.3 (CH3);
reduced pressure to give the crude product, which was purified ESIMS: 951.3 [M + Na]+; Anal. calcd for C42H56O23: C, 54.31;
over SiO2 by using hexane/EtOAc (1:1) as an eluant to give H, 6.08; found: C, 54.18; H, 6.25.
pure compound 7 (2.8 g, 80%). Yellow oil; [α]D25 −30 (c 1.2,
CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.28–7.18 (m, 5H, 2-Phenylethyl (α-L-rhamnopyranosyl)-(1→3)-[β-D-glucopy-
Ar-H), 5.23 (dd, J = 10.0, 3.5 Hz, 1H, H-3B), 5.10–5.09 (m, 1H, ranosyl)-(1→6)]-β-D-glucopyranoside (1): A solution of com-
H-2B), 5.05 (t, J = 10.0 Hz, 1H, H-4B), 4.94 (t, J = 8.0 Hz, 1H, pound 8 (2.0 g, 2.15 mmol) in 0.1 M CH3ONa in CH3OH
H-2A), 4.87 (d, J = 1.8 Hz, 1H, H-1B), 4.41 (d, J = 8.0 Hz, 1H, (50 mL) was stirred at room temperature for 3 h and neutral-
H-1A), 4.16–4.06 (m, 2H, CH2), 3.92–3.86 (m, 1H, H-6aA), ized with Amberlite IR-120 (H+) resin. The reaction mixture
3.82–3.78 (m, 1H, H-6bA), 3.69–3.61 (m, 2H, H-3A, H-5B), was filtered and concentrated to give the crude product, which
3.58 (t, J = 9.0 Hz, 1H, H-4A), 3.54–3.31 (m, 1H, H-5A), was purified over Sephadex® LH-20 gel by using CH3OH/H2O
2.91–2.83 (m, 2H, CH2), 2.13, 2.04, 2.01, 1.98 (4 s, 12H, (10:1) as an eluant to give pure compound 1 (1.2 g, 94%).
4 COCH3), 1.21 (d, J = 6.0 Hz, 3H, CH3); 13C NMR White powder; [α]D25 −11 (c 1.2, CH3OH); 1H NMR
(125 MHZ, CDCl3) δ 170.0, 169.9, 169.7, 169.5 (4 COCH3), (500 MHz, CD3OD) δ 7.26–7.16 (m, 5H, Ar-H), 5.16 (br s, 1H,
138.5–126.3 (Ar-C), 100.7 (C-1A), 98.8 (C-1B), 84.8 (C-4A), H-1B), 4.37 (d, J = 7.5 Hz, 1H, H-1A), 4.32 (d, J = 8.0 Hz, 1H,
75.2 (C-3A), 71.4 (C-2A), 70.7 (C-4B), 70.4 (C-2B), 69.9 (2C, H-1C), 4.15–4.13 (m, 1H, H-6aC), 4.10–4.04 (m, 1H, CH2),
C-5B, CH2), 68.6 (C-3B), 67.7 (C-5A), 62.2 (C-6A), 36.0 (CH2), 4.03–3.98 (m, 1H, H-5B), 3.95–3.92 (m, 1H, H-2B), 3.88–3.82
20.9, 20.8, 20.7, 20.6 (4 COCH3), 17.4 (CH3); ESIMS: 621.2 (m, 1H, H-6aA), 3.81–3.73 (m, 2H, H-6bC, CH2), 3.70 (dd,
[M + Na]+; Anal. calcd for C28H38O14: C, 56.18; H, 6.40; J = 10.0, 3.5 Hz, 1H, H-3B), 3.68–3.64 (m, 1H, H-6bA), 3.50 (t,
found: C, 56.05; H, 6.55.
J = 10.0 Hz, 1H, H-4A), 3.48–3.44 (m, 2H, H-4B, H-5A), 3.39
(t, J = 10.0 Hz, 1H, H-4C), 3.30–3.35 (m, 4H, H-2A, H-3A,
2-Phenylethyl (2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl)- H-3C, H-5C), 3.21 (t, J = 9.0 Hz, 1H, H-2C), 2.94–2.90 (m, 2H,
(1→3)-[2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)]- CH2), 1.25 (d, J = 6.0 Hz, 3H, CH3); 13C NMR (125 MHz,
2-O-acetyl-β-D-glucopyranoside (8): A solution of compound CD3OD) δ 138.6–125.8 (Ar-C), 103.5 (C-1A), 102.9 (C-1C),
4 (1.7 g, 3.45 mmol) and compound 7 (2.0 g, 3.34 mmol) in an- 101.3 (C-1B), 82.6 (C-4A), 76.6 (2C, C-3A, C-3C), 75.6 (C-5A),
hydrous CH2Cl2 (20 mL) was cooled to −35 °C under argon. To 74.3 (C-5C), 73.7 (C-2C), 72.6 (C-4C), 71.0 (C-4B), 70.9
the cooled reaction mixture was added NOBF4 (410 mg, (C-2A), 70.6 (CH2), 70.2 (C-2B), 68.6 (C-3B), 68.5 (C-5B), 68.3
3.51 mmol), and the reaction mixture was stirred at the same (C-6C), 61.3 (C-6A), 35.8 (CH2), 16.5 (CH3); ESIMS: 615.2 [M
temperature for 30 min. The reaction mixture was diluted with + Na]+; Anal. calcd for C26H40O15: C, 52.70; H, 6.80; found: C,
CH2Cl2 (100 mL), and the organic layer was washed with satd. 52.56; H, 7.0.
NaHCO3 and water, dried (Na2SO4), and concentrated to a
crude product, which was purified over SiO2 by using hexane/
Supporting Information
EtOAc (3:1) as an eluant to give the pure product 8 (2.2 g,
71%). Yellow oil; [α]D25 −32 (c 1.2, CHCl3); 1H NMR
Supporting Information File 1
(500 MHz, CDCl3) δ 7.17–7.07 (m, 5H, Ar-H), 5.12 (dd,
J = 10.0, 3.5 Hz, 1H, H-3B), 5.07 (t, J = 10.0 Hz, 1H, H-3C),
4.99–4.93 (m, 3H, H-2B, H-4B, H-4C), 4.89 (t, J = 10.0 Hz, 1H,
H-2C), 4.82 (t, J = 10.0 Hz, 1H, H-2A), 4.75 (br s, 1H, H-1B),
4.54 (d, J = 8.0 Hz, 1H, H-1C), 4.22 (d, J = 8.0 Hz, 1H, H-1A),
4.16 (dd, J = 12.0, 5.0 Hz, 1H, H-6aC), 4.07–3.96 (m, H-6aA,
H-6bC, CH2), 3.69–3.65 (m, 1H, H-6bA), 3.60–3.56 (m, 1H,
H-5A), 3.55–3.48 (m, 1H, CH2), 3.43 (t, J = 10.0 Hz, 1H,
H-3A), 3.42–3.35 (m, 1H, H-5C), 3.33–3.31 (m, 1H, H-5B),
2.77–2.74 (m, 2H, CH2), 2.08, 2.07, 2.01, 2.00, 1.99, 1.96, 1.94,
1.90 (8 s, 24H, 8 COCH3), 1.10 (d, J = 6.0 Hz, 3H, CH3);
13C NMR (125 MHz, CDCl3) δ 170.7, 170.2, 170.0, 169.9,
169.6, 169.4, 169.3, 169.2 (8 COCH3), 138.6–126.2 (Ar-C),
100.8 (C-1A), 100.5 (C-1C), 98.8 (C-1B), 84.3 (C-5C), 74.8
(C-5B), 72.7 (C-3C), 71.9 (C-4A), 71.5 (C-2B), 71.1 (C-5A),
70.8 (C-2C), 70.3 (CH2), 70.2 (C-2A), 70.0 (C-3A), 68.7 (C-6A),
1H NMR and 13C NMR spectra of compounds 1, 2, 5, 6, 7
and 8.
Acknowledgements
G. G. thanks CSIR, New Delhi for providing a Senior Research
Fellowship. This work was supported by CSIR, New Delhi
[Project No. 02 (0038)/11/EMR-II].
References
1. Kobayashi, H.; Oguchi, H.; Takizawa, N.; Miyase, T.; Ueno, A.;
Usmanghani, K.; Ahmad, M. Chem. Pharm. Bull. 1987, 35, 3309–3314.
708